Tufts Center for Drug Development Study Quantifies Multimillion-Dollar Benefits of Using Single-Source Pharma Drug Development and Manufacturing Model
Tufts Center for Drug Development Study Quantifies Multimillion-Dollar Benefits of Using Single-Source Pharma Drug Development and Manufacturing Model DURHAM, N.C., Oct. 24, 2017 /PRNewswire/ — A newly released modeling study conducted by The Tufts Center for the Study of Drug Development (CSDD) finds that sponsors who employ single-source outsourcing partners, versus a multivendor development and... Read more